221 Users Online
Automated Cell Counters Market Segmented By Systems Type, Reagents & Consumables Product for Blood Analysis, Urine Analysis, Microbial Cell, Count Cell, Line Viability Application
Automated cell counters are commonly used in laboratory tests to count cells. The increased frequency of illnesses such as HIV, measles, diphtheria, and chronic diseases such as cancer and the other blood disorders is a significant factor driving the market growth. The importance of cell count in COVID-19 patients is likely to boost the market in the coming years. The Global Automated cell counters market is expected to witness a CAGR of 5.8% from USD 6,499.2 Million in 2022 to USD 9,636.8 Million in 2029.
| Attribute | Key Insights |
|---|---|
|
Automated Cell Counters Market Size (2022) |
US$ 6,499.2 Mn |
|
Projected Market Value (2028) |
US$ 9,636.8 Mn |
|
Global Market Growth Rate (2022 - 2029) |
5.8% CAGR |
|
Share in parent market |
57.6% |
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Every year, the number of people suffering from various ailments increases, thereby creating a market for automated cell counters. Furthermore, the rise in the prevalence of various types of cancers is driving the automated cell counters market. The global automated cell counters market is expected to grow rapidly in the upcoming period because they are commonly used in laboratory testing to count cells. Cell counting, as the name suggests, is a counting method used in medical applications that is essential in research and clinical activities. Many therapy procedures need cell counts in order to carry out additional procedures. Cell counting is a common diagnostic and research laboratory practice in biotechnology, pharmacy, and medicine. Automated cell counters are intended to solve the challenges associated with manual cell counting. Automated cell counters are important in determining blood cell concentrations, presence of pathogens, harmful effects of drugs on model cells, etc.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionIncreasing Prevalence of Chronic And Infectious Diseases
The rising prevalence of chronic and infectious diseases such as cancer, AIDS, sepsis, malaria, influenza, measles, cholera, and vector-borne diseases such as chikungunya and polio are important factors driving the growth of the global automated cell counting market. The growing necessity for cell counting in the diagnosis and treatment of such life-threatening diseases will boost the automated cell counting market. According to the World Health Organization (WHO), it is estimated that roughly 37.7 million people globally had HIV at the end of 2020 in November 2021. Furthermore, according to the same source, 680,000 people had died from HIV-related causes in 2020. As a result, the rising incidences of infectious diseases are expected to significantly boost the market growth.
Big Data technologies are assisting researchers in identifying patterns between new diseases and genetic factors. This is likely to yield positive outcomes for future studies, as the capacity to identify illnesses has the potential to significantly cut patient costs and result in better quality treatment going forward. Medical image analysis software and informatics platforms in automated cell counters have revolutionized cell-based research, which is likely to drive the demand for device-automated cell counters. Rapid scientific and technological advancements are projected to drive market growth in the long run.
Increased investments by governments and corporations have enabled tremendous expansion in the global healthcare sectors. These significant investments are enabling research centers, educational institutes, hospitals, and the other medical establishments to table the latest technology in the market. The increasing inflow of funding is likely to generate enormous potential prospects for the Automated Cell Counters market.
“High Costs, Scarcity of Skilled Professionals, and Poor Healthcare Infrastructure”
People are hesitant to invest money in cell counting procedures for medical or research purposes due to the high expense of the apparatus, equipment, and procedures. Furthermore, in impoverished nations, undeveloped healthcare infrastructure and obsolete technology limit the growth of automated cell counting. In addition, scarcity of trained specialists is impeding the expansion of the automated cell counting market. The healthcare industry is also experiencing a serious scarcity of trained workers and skilled doctors, which will impede market growth in the long run.
Sales Team
Client Partner
The COVID-19 outbreak had a significant impact on the market for automated cell counter devices. During the pandemic, there was a considerable rise in the use of automated cell counting devices, as eosinopenia and lymphopenia were potential indicators of COVID-19. The increasing importance of cell count in COVID-19 patients fueled market growth during the pandemic and is expected to keep driving the market growth in the coming years.
The Automated Cell Counters Market is moderately competitive. The major players in the automated cell counters market are implementing innovative and differentiated methods to fulfill product demand and dominate the regional market. To increase their global market presence, these companies are adopting new strategies and policies, like post-sales and service agreements, extensive research for developing new products, partnerships, mergers and acquisitions.
| Attribute | Details |
|---|---|
|
Forecast Period |
2022 - 2029 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
US$ Mn/Bn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
By Product |
|
Key Companies Profiled |
|
|
Customization & Pricing |
Available upon Request |
Automated Cell Counters Market by Product
Automated Cell Counters Market by Application
Automated Cell Counters Market by Region
In 2022, the Automated Cell Counters Market stands at USD 6,499.2 million, and it is expected to reach USD 9,636.8 million by 2029 at a CAGR of 5.8%.
Automated Cell Counters Market exhibited a CAGR of 5.4% between 2014 and 2021.
Costs, Scarcity of Skilled Professionals, and Poor Healthcare Infrastructure are the key restraints in the Automated Cell Counters Market.
Increasing Prevalence of Chronic and Infectious Diseases are the key factors driving the growth of the market.
Danaher Corporation, Biotek Instruments, Inc., Alere Inc., and Bio-Rad Laboratories, Inc. are among the top players in the market.
